[1] Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer[J]. J Natl Cancer Inst, 2011, 103(5): 368-383.
[2] Catellsagué X, Bosch FX, Muoz N. Environmental co-factors in HPV carcinogenesis[J]. Virus Res, 2002, 89(2): 191-199.
[3] 王巧燕, 陈伟华. 国内 HPV DNA 检测的常见方法比较[J]. 检验医学,2012,27(1):71-74.
[4] Castellsagué X, Diaz M, De Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention[J]. J Natl Cancer Inst, 2006, 98(5): 303-315.
[5] 宋丽君,陈春丽,罗淑桂. HPV基因分型检测与宫颈病变的相关性研究[J]. 检验医学,2012, 27(3):163-166.
[6] Wattleworth R. Human papillomavirus infection and the links to penile and cervical cancer[J]. J Am Osteopath Assoc, 2011, 111(3 Suppl 2): S3-S10.
[7] 洪水清,毛勤尔,傅亚仙,等.杭州市萧山区妇女人乳头瘤病毒感染现况及影响因素分析[J]. 肿瘤学杂志,2010,16 (12) : 965-967.
[8] Faridi A, Zahra A, Khan K, et al. Oncogenic potential of human papillomavirus(HPV) and its relation with cervical cancer[J]. Virol J, 2011, 8: 269.
[9] Tricco AC, Ng CH, Gilca V, et al. Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis[J].BMC Infect Dis, 2011,11: 235.
[10] Smith GD, Travis L. Getting to know human papilloma- virus(HPV) and the HPV vaccines[J]. J Am Osteopath Assoc, 2011, 111(3 Suppl 2): S29-S34. |